Long-term follow up of breast cancer patients treated for hypercalcaemia with aminohydroxypropylidene bisphosphonate (APD)
- 1 January 1993
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 25 (3) , 277-281
- https://doi.org/10.1007/bf00689842
Abstract
No systematic data are available about the long-term follow up of breast cancer patients treated with aminohydroxypropylidene bisphosphonate (APD) for hypercalcaemia and about the results of APD treatment of recurrent hypercalcaemia in these patients.Keywords
This publication has 3 references indexed in Scilit:
- Response to retreatment of malignant hypercalcemia with the bisphosphonate AHPrBP (APD): Respective role of kidney and boneJournal of Bone and Mineral Research, 1990
- Single dose versus daily intravenous aminohydroxypropylidene biphosphonate (APD) for the hypercalcaemia of malignancyBMJ, 1988
- Reporting results of cancer treatmentCancer, 1981